Literature DB >> 6803286

Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.

W H Riffee, R E Wilcox, C P Goldman, R V Smith.   

Abstract

Based on previous work examining the effects of dextroamphetamine on pentylenetetrazol (PTZ)-induced clonic seizure threshold, the objective of the present study was to determine the effects of two other dopamine agonists, apomorphine (AP) and piribedil, on PTZ seizures. TD50 and LD50 values for CD-1 mice were determined initially for the two drugs. Subsequently, dose- and time-response analyses established that AP decreased PTZ seizure threshold 15 min after administraton, but increased the threshold at 60 min. Piribedil elevated the seizure threshold, but like AP, did not exhibit a clear dose-response relationship. Subsequent blocker studies with phentolamine, (-)sotalol, pimozide, and atropine suggested the possible neurotransmitter systems involved in the modulation of the PTZ-induced seizures by AP and piribedil. Pimozide blocked the changes in seizure threshold induced by both drugs. Atropine also decreased the AP-induced increase in threshold at 60 min. The pattern of inhibition of seizure threshold changes induced by the neurotransmitter blockers suggested that piribedil blocked seizures by means of indirect actions on several neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6803286     DOI: 10.1007/BF00435860

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice.

Authors:  W H Riffee; M C Gerald
Journal:  Neuropharmacology       Date:  1976-11       Impact factor: 5.250

2.  Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs.

Authors:  M J ORLOFF; H L WILLIAMS; C C PFEIFFER
Journal:  Proc Soc Exp Biol Med       Date:  1949-02

Review 3.  Pharmacology and neurochemistry of apomorphine.

Authors:  G Di Chiara; G L Gessa
Journal:  Adv Pharmacol Chemother       Date:  1978

4.  The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions--a comparative study in the rat and mouse.

Authors:  G M McKenzie; F E Soroko
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

5.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

6.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

7.  The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  Parkinson disease treated with a suspected dopamine receptor agonist.

Authors:  T N Chase; A C Woods; G A Glaubiger
Journal:  Arch Neurol       Date:  1974-05

9.  Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.

Authors:  P G Guyenet; A F Javory; J C Beaujouan; B J Rossier; J Glowinski
Journal:  Brain Res       Date:  1975-02-07       Impact factor: 3.252

10.  Apomorphine and piribedil in rats: biochemical and pharmacologic studies.

Authors:  R F Butterworth; J C Poignant; A Barbeau
Journal:  Adv Neurol       Date:  1975
View more
  1 in total

1.  Effects of ascorbate on a dopaminergic response: apomorphine-induced modification of pentylenetetrazol-induced seizures in mice.

Authors:  R E Wilcox; W H Riffee; C P Goldman; R K Young
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.